Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1703 of 6351
-
VR video games could be the new treatment for lazy eye in children
Disease control Recruiting nowParticipants eligible for the study will be randomly allocated (1:1:1) to receive either Luminopia dichoptic treatment while wearing optical correction if needed, Vivid Vision dichoptic treatment while wearing optical correction if needed, or continued optical correction alone if…
Phase 3 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug cocktail aims to shrink prostate tumors before surgery
Disease control Recruiting nowThe goal of this clinical trial is to determine the safety and feasibility of a new combination of darolutamide and relugolix as neoadjuvant therapy preceding radical prostatectomy (RP) for high-risk prostate cancer (PCa) in adult males.
Phase 1 • Sponsor: AdventHealth • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New pill aims to soothe Alzheimer's agitation in major trial
Symptom relief Recruiting nowThis is a multicenter, randomized, double-blind, placebo-controlled, flexible-dose study of the efficacy, safety, and tolerability of ITI-1284 in patients with agitation associated with Alzheimer's dementia.
Phase 2 • Sponsor: Intra-Cellular Therapies, Inc. • Aim: Symptom relief
Last updated Aug 28, 2026 00:00 UTC
-
New device aims to quiet overactive bladder in men
Symptom relief Recruiting nowTo assess the post-market clinical outcomes of the Axonics SNM System for treatment of overactive bladder in male patients.
Sponsor: Axonics, Inc. • Aim: Symptom relief
Last updated Aug 14, 2026 00:00 UTC
-
Dissolvable scaffold for leg arteries under Real-World watch
Disease control OngoingThe Esprit BTK PAS is a prospective, single-arm, multi-center observational study to assess the continued safety and effectiveness of the Esprit™ BTK Everolimus Eluting Resorbable Scaffold System under commercial use, in patients with diseased infrapopliteal lesions causing CLTI …
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
3D printed aligners could transform cleft lip care for newborns
Disease control Recruiting nowstudy will provide nasoalveolar molding (NAM) treatment, special care for infants born with cleft lip and palate. This novel appliance will help to provide the care in accurate and easy form by help of both digital work flow and new material which provide a unique properties.
Sponsor: Ain Shams University • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Classroom lights and phone apps aim to stop Kids' Short-Sightedness
Prevention Recruiting nowThe goal of this clinical trial is to evaluate whether the optimization of daily exposure to light in primary school children can lead to better myopia prevention and control. The trial also aims to better understand the impact of light exposure on sleep and cognitive performance…
Sponsor: National University of Singapore • Aim: Prevention
Last updated Jun 27, 2026 07:51 UTC
-
Could amniotic fluid injections ease knee arthritis pain?
Disease control Recruiting nowThere have been few clinical trials on ASA for the treatment of knee osteoarthritis, and there is currently no literature reporting the optimal treatment dosage. Non-surgical treatment options include braces, weight loss, lifestyle changes, oral pain relievers, and intra-articula…
Phase 3 • Sponsor: Chang Gung Memorial Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:14 UTC
-
Hope for rare obesity: setmelanotide tested for long-term safety
Disease control CompletedThis is an open-label extension study designed to evaluate the long-term safety and tolerability of continued setmelanotide treatment in male and female patients ≥2 years of age who have completed or transitioned from a previous study with setmelanotide for rare genetic, syndromi…
Phase 3 • Sponsor: Rhythm Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New hope for rare genetic disorder: drug ION440 enters human trials
Disease control Recruiting nowThe primary purpose of this study is to evaluate the safety and tolerability of ION440.
Phase 1/2 • Sponsor: Ionis Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New pill targets multiple KRAS mutations in Hard-to-Treat cancers
Disease control OngoingThe main purpose of the study is to assess whether the study drug, LY4066434, is safe and tolerable when administered to participants with locally advanced or metastatic solid tumors with certain KRAS mutations. LY4066434 will be given alone or in combination with other treatment…
Phase 1 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New embryo transfer device aims to boost IVF success
Disease control Recruiting nowInfertility is defined as the inability to conceive within a year of unprotected intercourse. Infertility affects one in six couples and represents a public health problem causing feelings of helplessness, depression, and anxiety in both women and men worldwide. Despite the desir…
Sponsor: Premium Fertility • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
Magnetic pulses to the brain may help stroke survivors move again
Symptom relief CompletedThis is a multicenter, sham-controlled, double-blind, randomized clinical trial to evaluate the efficacy and safety of lesion network mapping navigated cTBS in improving motor function in patients with acute ischemic stroke within 14 days of symptom onset.
Phase 2 • Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:05 UTC
-
New pill shows promise for rare blood cancers in early trial
Disease control Recruiting nowThis study aims to assess the safety and efficacy of orally administered JBI-802 in subjects with Myeloproliferative Neoplasms (MPN) and Myelodysplastic/ Myeloproliferative Neoplasms (MDS/MPN) with Thrombocytosis. Who is it for? You may be eligible to join this study if you are …
Phase 1/2 • Sponsor: Jubilant Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Can a Two-Session acupuncture treatment match ten sessions for carpal tunnel?
Symptom relief CompletedThis study compared thread-embedding acupuncture with electroacupuncture for adults with mild-to-moderate carpal tunnel syndrome confirmed by electrodiagnosis. Eighty participants were randomly assigned in a 1:1 ratio to receive either thread-embedding acupuncture or electroacupu…
Sponsor: University of Medicine and Pharmacy at Ho Chi Minh City • Aim: Symptom relief
Last updated Aug 29, 2026 00:00 UTC
-
New drug aims to calm overactive immune system in rare disorders
Disease control OngoingThis study is an exploratory, non-randomized, open-label, within-patient dose escalation study. The primary objective is to assess safety and tolerability of leniolisib. Secondary objectives include assessments of PK/PD, and to explore clinical efficacy measures with administrati…
Phase 2 • Sponsor: Pharming Technologies B.V. • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
Could a brief therapy tame OCD? new pakistan trial aims to find out
Symptom relief Recruiting nowThe purpose aims to assess the efficacy of Brief Culturally Adapted Cognitive Behaviour Therapy (Ca-CBT) for the treatment of Obsessive Compulsive Disorder (OCD).
Sponsor: Pakistan Association of Cognitive Therapists • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New combo shot may cut migraine days in half
Symptom relief CompletedThis is a multicenter, prospective, observational, propensity score matching, cohort, and assessor-blinded study designed to compare the effectiveness and safety of lidocaine combined Platelet-rich plasma (PRP) acting on SGB versus lidocaine alone acting on SGB in patients with C…
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:04 UTC
-
Can brain zaps and yoga quiet knee pain?
Symptom relief Recruiting nowPeople with knee arthritis often experience constant pain, and current treatments aren't very effective. This can lead to limited movement and more health problems. Knee arthritis is a big part of healthcare costs in Canada, and its pain is a major reason people see doctors. The …
Sponsor: McMaster University • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
Could a simple nerve block ease menstrual migraines?
Symptom relief Completed: The primary objective of this prospective, randomized, double-blind, placebo-controlled clinical trial is to evaluate whether repetitive bilateral greater occipital nerve (GON) blockade administered with a local anesthetic (0.5% bupivacaine) significantly reduces headache sever…
Sponsor: Saglik Bilimleri Universitesi • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC